Clinical trial
Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck…
NCT00121316 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00121316 |
|---|---|
| Title | Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients |
| Official title | Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) of Patients Intolerant to, or Dependant on, Topical Corticosteroids |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Pimecrolimus, Placebo |
| Enrollment | 200 |
| Start date | Oct 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Jul 21, 2005 |
| Last update posted | Jan 15, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: